$570 Million is the total value of Bronte Capital Management Pty Ltd.'s 11 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 15.4% . Bronte Capital Management Pty Ltd. is a registered-investment adviser.
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TRcall | $124,012,000 | +20.0% | 40,000 | 0.0% | 21.75% | +28.5% | |
| HLF | Sell | HERBALIFE NUTRITION LTD | $93,732,000 | +38.9% | 2,083,862 | -10.0% | 16.44% | +48.8% |
| V | Buy | VISA INC | $78,519,000 | +20.9% | 406,475 | +0.8% | 13.77% | +29.5% |
| BRKB | Buy | BERKSHIRE HATHAWAY INC DELcl b new | $72,406,000 | +2.7% | 405,613 | +5.2% | 12.70% | +10.0% |
| GOOGL | Buy | ALPHABET INCcap stk cl a | $61,248,000 | +30.9% | 43,192 | +7.2% | 10.74% | +40.2% |
| IBKR | Buy | INTERACTIVE BROKERS GROUP | $51,834,000 | +1.9% | 1,240,933 | +5.3% | 9.09% | +9.2% |
| GOOG | Sell | ALPHABET INCcap stk cl c | $22,967,000 | +18.6% | 16,247 | -2.5% | 4.03% | +27.0% |
| CTVA | Sell | CORTEVA NC | $22,421,000 | +9.5% | 836,923 | -3.9% | 3.93% | +17.4% |
| NEM | Buy | NEWMONT CORP | $20,230,000 | +71.8% | 327,666 | +26.0% | 3.55% | +84.1% |
| GDX | Buy | VANECK VECTORS ETF TRgold miners etf | $15,433,000 | +67.5% | 420,737 | +5.2% | 2.71% | +79.4% |
| GDXJ | Buy | VANECK VECTORS ETF TRjr gold miners e | $7,311,000 | +85.8% | 147,463 | +5.3% | 1.28% | +99.1% |
| FB | Exit | FACEBOOK INCcl a | $0 | – | -72,462 | -100.0% | -1.98% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -50,300 | -100.0% | -21.28% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2020-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL | 20 | Q3 2023 | 22.6% |
| ALPHABET INC-CL A | 20 | Q3 2023 | 14.4% |
| HERBALIFE NUTRITION LTD | 20 | Q3 2023 | 22.0% |
| INTERACTIVE BROKERS GROUP | 20 | Q3 2023 | 12.4% |
| ALPHABET INC-CL C | 20 | Q3 2023 | 5.7% |
| VISA INC-CLASS A SHARES | 19 | Q2 2023 | 16.6% |
| CORTEVA NC | 17 | Q3 2023 | 6.2% |
| GRAHAM HOLDINGS CO-CLASS B | 13 | Q3 2023 | 2.1% |
| REGENERON PHARMACEUTICALS | 12 | Q3 2023 | 13.0% |
| STATE STREET CORP | 12 | Q2 2023 | 3.0% |
View Bronte Capital Management Pty Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-13 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-03 |
| 13F-HR/A | 2022-08-08 |
| 13F-HR | 2022-08-08 |
| 13F-HR | 2022-05-13 |
View Bronte Capital Management Pty Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.